Formosa Laboratories, Inc. (TPE: 4746)

Formosa Laboratories Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	916.32	1,526	1,279	729.54	581.01	453.77
Short-Term Investments	866.59	831.41	153.55	-	-	20
Trading Asset Securities	149.7	153.07	197.52	363.95	210.73	6.09
Cash & Short-Term Investments	1,933	2,510	1,631	1,093	791.74	479.86
Cash Growth	-9.02%	53.97%	49.11%	38.11%	64.99%	-45.33%
Accounts Receivable	1,167	960.01	812.48	773.77	759.5	886.92
Other Receivables	59.42	64.44	14.65	29.42	25.3	19.61
Receivables	1,227	1,024	827.13	803.19	784.8	906.54
Inventory	1,783	1,597	1,602	1,639	1,451	1,247
Prepaid Expenses	142.17	109.24	89.49	79.81	93.41	110.46
Other Current Assets	2.25	2.02	2.24	3.81	27.24	4.65
Total Current Assets	5,086	5,244	4,151	3,619	3,148	2,749
Property, Plant & Equipment	6,127	6,068	5,919	5,901	5,801	5,495
Long-Term Investments	1,824	1,950	2,254	2,083	846.36	778.77
Goodwill	60.4	30.54	30.54	30.54	30.54	30.54
Other Intangible Assets	165.28	173.89	192.39	217.06	237.72	246.04
Long-Term Deferred Tax Assets	86.21	85.15	97.19	72.3	89.37	109.56
Other Long-Term Assets	57.85	85.42	106.5	93.43	132.92	162.71
Total Assets	13,407	13,636	12,751	12,017	10,286	9,572
Accounts Payable	228.39	203.13	187.49	204.05	208.14	267.92
Accrued Expenses	490.98	467.89	466.82	398.37	266.54	220.64
Short-Term Debt	876.49	1,534	1,500	1,177	1,268	1,012
Current Portion of Long-Term Debt	455.79	448.78	619.02	284.86	1,010	600.51
Current Portion of Leases	25.02	23.36	22.09	27.74	26.32	30.49
Current Income Taxes Payable	89.98	98.7	141.37	22.89	37.36	6.9
Current Unearned Revenue	72.91	174.88	55.78	109.69	42.06	9.83
Other Current Liabilities	555.25	290.69	149.5	160.87	181.98	324.83
Total Current Liabilities	2,795	3,241	3,142	2,386	3,040	2,473
Long-Term Debt	2,287	2,038	1,638	1,907	1,846	2,457
Long-Term Leases	87.07	19.39	21.44	23.5	23.02	48.7
Long-Term Unearned Revenue	30.23	18.23	16.99	-	-	-
Long-Term Deferred Tax Liabilities	22.72	24.3	24.63	23.95	23.46	24.04
Other Long-Term Liabilities	64.9	61.41	95.13	57.2	48.37	94.38
Total Liabilities	5,310	5,426	4,954	4,415	5,000	5,114
Common Stock	1,203	1,203	1,203	1,203	1,083	990.13
Additional Paid-In Capital	3,569	3,552	3,514	3,503	2,733	2,384
Retained Earnings	2,758	2,810	2,809	2,640	1,390	991.67
Comprensive Income & Other	-13.77	6.17	-5.7	49.26	-0.27	-3.87
Total Common Equity	7,515	7,571	7,521	7,395	5,205	4,362
Minority Interest	581.82	639.25	275.63	206.94	80.64	95.51
Shareholders' Equity	8,097	8,210	7,796	7,602	5,286	4,457
Total Liabilities & Equity	13,407	13,636	12,751	12,017	10,286	9,572
Total Debt	3,732	4,063	3,800	3,420	4,173	4,149
Net Cash (Debt)	-1,799	-1,553	-2,169	-2,327	-3,381	-3,670
Net Cash Per Share	-14.94	-12.89	-17.95	-19.15	-28.61	-36.94
Filing Date Shares Outstanding	120.26	120.26	120.26	120.26	108.31	99.01
Total Common Shares Outstanding	120.26	120.26	120.26	120.26	108.31	99.01
Working Capital	2,292	2,002	1,009	1,234	108.26	275.27
Book Value Per Share	62.49	62.96	62.54	61.50	48.06	44.05
Tangible Book Value	7,289	7,367	7,298	7,148	4,937	4,085
Tangible Book Value Per Share	60.62	61.26	60.68	59.44	45.58	41.26
Land	655.95	655.95	655.95	655.95	655.95	655.95
Buildings	2,388	2,377	1,598	1,575	1,517	1,112
Machinery	4,569	4,479	4,116	3,939	3,825	3,146
Construction In Progress	2,068	1,957	2,527	2,294	2,045	2,410
Leasehold Improvements	21.33	15.7	16.78	16.78	16.56	16.01

Source: S&P Capital IQ. Standard template. Financial Sources.